| A Phase I/II Study of Recombinant Botulinum Toxin Type A for the Treatment of Moderate to Severe Glabellar Lines (NCT05743634) | Chongqing Claruvis Pharmaceutical Co., Ltd. | 2022-03-22 |
| Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer. (NCT04655365) | CHU de Quebec-Universite Laval | 2022-03-22 |
| A Randomized Pilot Study of Evolocumab Plus Nivolumab/Ipilimumab in Treatment-Naïve Patients With Metastatic NSCLC (NCT05144529) | Eziafa Oduah, MD, PhD, MPH | 2022-03-22 |
| Timing of Post-prostatectomy PSMA Imaging (NCT05008900) | University Health Network, Toronto | 2022-03-22 |
| Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes (NCT05180591) | Massachusetts General Hospital | 2022-03-22 |
| The Purpose of This Trial is to Determine if Regorafenib Plus Durvalumab (MEDI4736) is Safe and Effective in Treatment of Chemo Refractory Advanced Biliary Tract Cancers (NCT04781192) | University of Kansas Medical Center | 2022-03-22 |
| Pharmacokinetics and Pharmacodynamics of Rifaximin Novel Formulations in Patients With Sickle Cell Disease (NCT05098028) | Bausch Health Americas, Inc. | 2022-03-22 |
| Anlotinib Combination With Vinorelbine in the HER2- Advanced Breast Cancer (NCT05296577) | Henan Cancer Hospital | 2022-03-22 |
| Safety and Preliminary Efficacy Trial of BNT142 in Patients With CLDN6-positive Solid Tumors (NCT05262530) | BioNTech SE | 2022-03-22 |
| Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis (NCT05019742) | Shanghai Pharma Biotherapeutics USA Inc. | 2022-03-21 |
| Deferoxamine Plus Chemotherapy for Metastatic Triple Negative Breast Cancer (NCT05300958) | Sun Yat-sen University | 2022-03-21 |
| FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer (NCT05077800) | Colin D. Weekes, M.D., PhD | 2022-03-21 |
| Cold-stored Platelet Early Intervention in TBI (NCT04726410) | Jason Sperry | 2022-03-21 |
| Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome (NCT04920149) | Ann-Sofie Backman | 2022-03-21 |
| Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant (NCT04933968) | AlloVir | 2022-03-21 |
| A Phase II Clinical Trial to Evaluate HLX208 in Advanced Melanoma Patients With BRAF V600 Mutation (NCT05114603) | Shanghai Henlius Biotech | 2022-03-21 |
| A Study to Assess Vamorolone in Boys Ages 2 to <4 Years and 7 to <18 Years With Duchenne Muscular Dystrophy (DMD) (NCT05185622) | Santhera Pharmaceuticals | 2022-03-21 |
| Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma or Transformed Indolent B-cell Lymphoma (NCT05202782) | Northwestern University | 2022-03-21 |
| Safety and Efficacy of AT-1501 in Patients With IgA Nephropathy (IgAN) (NCT05125068) | Eledon Pharmaceuticals | 2022-03-21 |
| Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC (NCT05239468) | Intercept Pharmaceuticals | 2022-03-21 |
| Ruxolitinib in Thrombocythemia and Polycythemia Vera (NCT04644211) | Massachusetts General Hospital | 2022-03-21 |
| Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy (NCT05398094) | Fundación GECP | 2022-03-21 |
| HFS (High-Fiber Supplement) in MS (Multiple Sclerosis) (NCT04574024) | Suhayl Dhib-Jalbut, MD | 2022-03-21 |
| Evaluating Safety, Tolerability, and Potential Efficacy of Intranasal AD17002 in Adults With Mild to Moderate COVID-19 (NCT05069610) | Advagene Biopharma Co. Ltd. | 2022-03-21 |
| Consolidation With Loncastuximab Tesirine After a Short Course of Immunochemotherapy in BTKi-treated (or Intolerant) Relapsed/Refractory Mantle Cell Lymphoma Patients. (NCT05249959) | Fondazione Italiana Linfomi - ETS | 2022-03-21 |
| Safety and Pharmacokinetics of FBR-002 for the Treatment of Patients Hospitalized With COVID-19 in Need of Supplemental Oxygen and at Risk of Severe Outcome (NCT05279352) | Fab'entech | 2022-03-21 |
| A Phase II Clinical Trial of Chiglitazar for NASH (NCT05193916) | Chipscreen Biosciences, Ltd. | 2022-03-21 |
| Effects of Photobiomodulation in Children With Down Syndrome and Possible Sleep Bruxism (NCT04211870) | University of Nove de Julho | 2022-03-20 |
| A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C in Population Aged ≥18 Years and Previously Fully Vaccinated With COVID-19 Vaccine (NCT05238454) | Sinocelltech Ltd. | 2022-03-20 |
| The Potential Use of Nebulized Hydroxychloroquine for the Treatment of COVID-19 (NCT05113810) | Ministry of Health Jordan | 2022-03-20 |
| Effectiveness of Glycyrrhizin as Intracanal Medication in Root Canal Disinfection and Inflammatory Cytokines (NCT06453304) | Mansoura University | 2022-03-20 |
| A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01E in Population Aged ≥18 Years Previously Fully Vaccinated With mRNA COVID-19 Vaccine (NCT05238441) | Sinocelltech Ltd. | 2022-03-20 |
| Deferoxamine In the Treatment of Aneurysmal Subarachnoid Hemorrhage (aSAH) (NCT04566991) | Aditya S. Pandey, MD | 2022-03-20 |
| Clinical Study of VG161 in Advanced Intrahepatic Cholangiocarcinoma (NCT06746480) | CNBG-Virogin Biotech (Shanghai) Ltd. | 2022-03-19 |
| Efficacy of Intracavernosal as add-on Therapy to Sildenafil 100 mg on Demand Compared to Sildenafil 100 mg on Demand for the Treatment of Erectile Dysfunction (ED) Not Sufficiently Responsive to Standard Therapy With Phosphodiesterase Type 5 Inhibitors (NCT05196308) | Assistance Publique - Hôpitaux de Paris | 2022-03-18 |
| Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis (NCT05096065) | Enteris BioPharma Inc. | 2022-03-18 |
| Senicapoc in Alzheimer's Disease (NCT04804241) | University of California, Davis | 2022-03-18 |
| Pomalidomide Treatment in Patients With Kaposi Sarcoma (NCT04577755) | National Cancer Institute (NCI) | 2022-03-18 |
| A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer (NCT05009069) | Hoffmann-La Roche | 2022-03-18 |
| Anti-malaria MAb in Malian Children (NCT05304611) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-03-18 |
| To Evaluate the Efficacy and Safety of Nemolizumab for 12 Weeks in Participants With Chronic Kidney Disease With Associated Moderate to Severe Pruritus (NCT05075408) | Galderma R&D | 2022-03-18 |
| STIMULUS MDS-US : Sabatolimab Added to HMA in Higher Risk MDS (NCT04878432) | Novartis Pharmaceuticals | 2022-03-17 |
| A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Sitravatinib as Maintenance Therapy for ES-SCLC (NCT05228496) | Zhejiang Cancer Hospital | 2022-03-17 |
| Radioligand fOr locAl raDiorecurrent proStaTe cancER (NCT05230251) | Glenn Bauman | 2022-03-17 |
| The Safety and Efficacy of an NAD+ Boosting Product Together With a Low Carbohydrate Diet in Adults With Mild Hypertension and Eligible for Normal-standard-of-care (NCT05298410) | Limitless Research Inc. | 2022-03-17 |
| AZD4205 in Peripheral T Cell Lymphoma Following First-Line Therapy (JACKPOT26) (NCT06511869) | Dizal Pharmaceuticals | 2022-03-17 |
| A Study Evaluating the Safety, Tolerability, and Range of Biologically Active Doses of ICM-203 in Mild to Moderate Knee Osteoarthritis (NCT04875754) | ICM Biotech Australia Pty Ltd. | 2022-03-17 |
| PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation (NCT05120570) | Masonic Cancer Center, University of Minnesota | 2022-03-17 |
| The Symptomatic Cerebral Cavernous Malformation Trial of REC-994 (NCT05085561) | Recursion Pharmaceuticals Inc. | 2022-03-17 |
| Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer (NCT04926181) | Rahul Aggarwal | 2022-03-16 |
| XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma (NCT05494060) | The First Affiliated Hospital with Nanjing Medical University | 2022-03-16 |
| A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT) (NCT05335122) | Ocular Therapeutix, Inc. | 2022-03-16 |
| Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis (NCT05158023) | ASLAN Pharmaceuticals | 2022-03-16 |
| POL6326 (Balixafortide) Plus Nab-paclitaxel or Eribulin in Patients With HER2-negative Advanced Breast Cancer (NCT04826016) | MedSIR | 2022-03-16 |
| Clinical Trial of SARS-CoV-2 mRNA Vaccine in Chinese People (NCT05352867) | AIM Vaccine Co., Ltd. | 2022-03-16 |
| Study of LM-108 as a Single Agent or in Combination With Anti-PD-1 Antibody in Subjects With Advanced Solid Tumours (NCT05199753) | LaNova Australia Pty Limited | 2022-03-16 |
| Zimberelimab (AB122) With TIGIT Inhibitor Domvanalimab (AB154) in PD-1 Relapsed/Refractory Melanoma (NCT05130177) | Diwakar Davar | 2022-03-16 |
| Enhanced CBTi for Older Adult Sleep and Cognition (NCT05015803) | Penn State University | 2022-03-16 |
| Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve Implantation (NCT05145283) | University Hospital, Basel, Switzerland | 2022-03-16 |
| Sirolimus for Nosebleeds in HHT (NCT05269849) | Unity Health Toronto | 2022-03-16 |
| A Trial of Hepatic Arterial Infusion Combined With Bevacizumab and Sintilimab for Unresectable A-staged Hepatocellular Carcinoma in BCLC Classification (D-TRIPLET) (NCT05214339) | Sun Yat-sen University | 2022-03-16 |
| Evaluation of Psilocybin (TRP-8802) in the Treatment of Binge Eating Disorder (NCT05035927) | TRYP Therapeutics | 2022-03-16 |
| Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With a Novel Form of Anaplerosis (NCT04513002) | The University of Queensland | 2022-03-15 |
| Testosterone Treatment in Men With Chronic Kidney Disease (NCT05249634) | St. Louis University | 2022-03-15 |
| Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease (NCT05254418) | Vanderbilt University Medical Center | 2022-03-15 |
| ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects in a Phase Ⅱ Clinical Trial (NCT06213727) | Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | 2022-03-15 |
| Safety, Tolerability, and Efficacy of AT101 in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma (NCT05338931) | AbClon | 2022-03-15 |
| Comparing Self-paced Versus Moderate Intensity Physical Activity Recommendation for Midlife Adults (NCT05285748) | Brown University | 2022-03-15 |
| CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol (NCT05648019) | KK Women's and Children's Hospital | 2022-03-15 |
| Comparative Study Between Topical 5-fluorouracil and Latanoprost in Vitiligo. (NCT05513924) | South Valley University | 2022-03-15 |
| A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3 (NCT05461105) | Hepion Pharmaceuticals, Inc. | 2022-03-15 |
| Initial Pain Management in Pediatric Pancreatitis: Opioid vs. Non-Opioid (NCT04291599) | Boston Children's Hospital | 2022-03-15 |
| Lifestyle Counseling and Medication for Adolescent Weight Management (NCT04873245) | University of Minnesota | 2022-03-15 |
| Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors (NCT05169437) | Tempus AI | 2022-03-15 |
| Feasibility of Home-based Exercise Program for Adults With Cystic Fibrosis (NCT05239611) | University of Kansas Medical Center | 2022-03-15 |
| A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Hematologic Malignancies (NCT05279859) | Erasca, Inc. | 2022-03-15 |
| RBN-2397 in Combination With Pembrolizumab in Patients With SCCL (NCT05127590) | Ribon Therapeutics, Inc. | 2022-03-15 |
| SBRT/LDRT in Combination With Camrelizumab and Apatinib in Metastatic Non-small Cell Lung Cancer Patient Previously Treated With PD-1/L1 Inhibitor and Chemotherapy (NCT04878107) | Wuhan University | 2022-03-15 |
| Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) (NCT05096663) | SWOG Cancer Research Network | 2022-03-15 |
| A Study to Investigate the Safety and Efficacy of GB1211 (a Galectin-3 Inhibitor) in Combination With Atezolizumab in Patients With Non-Small Cell Lung Cancer (NSCLC). (NCT05240131) | Galecto Biotech AB | 2022-03-15 |
| Anlotinib Combined With TQB2450 (PD-L1 Inhibitor) in the Treatment of Advanced Esophageal Squamous Cell Carcinoma(ESCC) (NCT05038813) | The First Affiliated Hospital of Zhengzhou University | 2022-03-14 |
| Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers (NCT05255107) | Peschke GmbH | 2022-03-14 |
| A Phase II Randomized Therapeutic Optimization Trial for Subjects With Refractory Metastatic Colorectal Cancer Using ctDNA: Rapid 1 Trial (NCT04786600) | University of Florida | 2022-03-14 |
| Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC (NCT05200988) | The Netherlands Cancer Institute | 2022-03-14 |
| Determination of In-vivo Plasma AA Appearance From Plant Protein Fibre Products (NCT05420142) | University College Dublin | 2022-03-14 |
| A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors (NCT05262400) | Pfizer | 2022-03-14 |
| Open-label Extension Study of ADP101 (NCT05243719) | Alladapt Immunotherapeutics, Inc. | 2022-03-14 |
| Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers (NCT05255016) | Peschke GmbH | 2022-03-14 |
| Methylphenidate in Childhood Apraxia of Speech (NCT05185583) | Murdoch Childrens Research Institute | 2022-03-14 |
| SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial (NCT05222620) | Mayo Clinic | 2022-03-14 |
| Study on Therapeutic Effect of Combination of Envafolimab, Lenavatinib and TACE in Advanced HCC Patients (NCT05213221) | Zhejiang University | 2022-03-14 |
| Sodium Nitroprusside in Early Course Schizophrenia (NCT04986072) | Beth Israel Deaconess Medical Center | 2022-03-14 |
| Herombopag for Chemotherapy-induced Thrombocytopenia (NCT05236582) | Institute of Hematology & Blood Diseases Hospital, China | 2022-03-14 |
| Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD) (NCT05289167) | Northwell Health | 2022-03-13 |
| Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial (NCT05290935) | Lei Li | 2022-03-13 |
| Low-Dose Dobutamine and Single-Dose Tocilizumab in Acute Myocardial Infarction With High Risk of Cardiogenic Shock (NCT05350592) | Rigshospitalet, Denmark | 2022-03-13 |
| Comparison of Combined Intravitreal Bevacizumab and Oral Acetazolamide Versus Intravitreal Bevacizumab Alone for the Treatment of Macular Edema Secondary to Retinal Vein Occlusions (NCT05290948) | Shahid Beheshti University of Medical Sciences | 2022-03-12 |
| Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL (NCT05082519) | Etan Orgel | 2022-03-12 |
| A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors (NCT05235542) | Akeso | 2022-03-12 |
| PD-1 Combined With Intensity Modulated Radiation Therapy in the Treatment of Intermediate-risk Nasopharyngeal Carcinoma (NCT05229315) | XIANG YANQUN | 2022-03-12 |